GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID ▲ | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/26:0)
|
1675.017178
|
C82H150N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/24:1(15Z))
|
1644.970228
|
C80H144N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/26:1(17Z))
|
1673.001528
|
C82H148N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/16:0)
|
1737.940052
|
C80H143N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/18:0)
|
1765.971352
|
C82H147N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/20:0)
|
1794.002652
|
C84H151N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/22:0)
|
1822.033952
|
C86H155N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/24:0)
|
1850.065252
|
C88H159N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/26:0)
|
1878.096552
|
C90H163N3O37
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/24:1(15Z))
|
1848.049602
|
C88H157N3O37
|
Displaying entries 201 - 210 of 3908 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
